Keay Nakae Analyst Performance

Analyst at Loop Capital

Keay Nakae is a stock analyst at Loop Capital focused in the medical sector, covering 36 publicly traded companies. Over the past year, Keay Nakae has issued 67 stock ratings, including buy and hold recommendations. While full access to Keay Nakae's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Keay Nakae's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
178 Last 10 Years
Buy Recommendations
92.00% 161 Buy Ratings
Companies Covered
36 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy92.0%161 ratings
Hold7.4%13 ratings
Sell0.6%1 ratings

Out of 175 total stock ratings issued by Keay Nakae at Loop Capital, the majority (92.0%) have been Buy recommendations, followed by 7.4% Hold and 0.6% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
88.9% of companies on NASDAQ
32 companies
NYSE
8.3% of companies on NYSE
3 companies
NYSEAMERICAN
2.8% of companies on NYSEAMERICAN
1 company

Keay Nakae, an analyst at Loop Capital, currently covers 36 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
35 companies
97.2%
Manufacturing
1 company
2.8%

Keay Nakae of Loop Capital specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
22 companies
61.1%
MED - DRUGS
5 companies
13.9%
PHARMACEUTICAL PREPARATIONS
4 companies
11.1%
MED PRODUCTS
2 companies
5.6%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
2.8%
BIOTECHNOLOGY
1 company
2.8%
MED INSTRUMENTS
1 company
2.8%

Keay Nakae's Ratings History at Loop Capital

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
6/17/2026Boost Price Target$3.66$16.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
6/12/2026Reiterated Rating$4.89$14.00Buy
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
6/10/2026Set Price Target$4.01$6.50Buy
CAMP4 Therapeutics Corporation stock logo
CAMP
CAMP4 Therapeutics
6/10/2026Initiated Coverage$4.34$6.50Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
4/22/2026Reiterated Rating$27.13$30.00Buy
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
4/9/2026Reiterated Rating$1.83$4.00Buy
iBio, Inc. stock logo
IBIO
iBio
4/9/2026Reiterated Rating$2.24$5.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
4/2/2026Reiterated Rating$23.38$30.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
3/30/2026Reiterated Rating$54.10$100.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
3/25/2026Reiterated Rating$326.30$425.00Buy
iBio, Inc. stock logo
IBIO
iBio
3/18/2026Reiterated Rating$2.46$5.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
3/18/2026Reiterated Rating$32.87$35.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
3/17/2026Reiterated Rating$24.27$30.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
3/16/2026Reiterated Rating$4.47$14.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
3/12/2026Reiterated Rating$4.38$20.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
3/11/2026Boost Price Target$4.54$14.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/9/2026Reiterated Rating$17.64$38.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/2/2026Reiterated Rating$16.15$38.00Buy
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
2/24/2026Set Price Target$26.21$45.00Buy
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
2/24/2026Set Price Target$18.23$45.00
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
2/13/2026Lower Price Target$308.48$425.00Buy
iBio, Inc. stock logo
IBIO
iBio
2/12/2026Reiterated Rating$2.21$5.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
1/29/2026Upgrade$11.69$15.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
1/29/2026Reiterated Rating$67.43$100.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
1/8/2026Reiterated Rating$5.12$14.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
1/7/2026Boost Price Target$70.81$80.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
1/5/2026Set Price Target$30.90$35.00
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
1/5/2026Reiterated Rating$6.20$40.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
1/5/2026Boost Price Target$30.90$35.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
1/5/2026Boost Price Target$16.61$30.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
12/18/2025Reiterated Rating$3.96$12.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
12/9/2025Reiterated Rating$22.20$38.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
12/1/2025Reiterated Rating$52.78$60.00Buy
Allurion Technologies, Inc. stock logo
ALUR
Allurion Technologies
11/20/2025Reiterated Rating$1.35Neutral
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
11/19/2025Reiterated Rating$40.47$60.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
11/17/2025Reiterated Rating$3.24$12.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
11/14/2025Reiterated Rating$5.96$14.00Buy
Arbutus Biopharma Corporation stock logo
ABUS
Arbutus Biopharma
11/14/2025Reiterated Rating$4.52$5.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
11/13/2025Reiterated Rating$31.42Neutral
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
11/13/2025Reiterated Rating$4.42$20.00Buy
How to play the Biggest IPO in stock market history! (Ad)

SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.tc pixel

Get all five tickers now, completely free
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
11/11/2025Reiterated Rating$69.84$72.00Neutral
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
11/9/2025Boost Price Target$80.95$100.00Buy
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
11/4/2025Reiterated Rating$2.59$4.00Buy
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/28/2025Reiterated Rating$70.00$72.00Neutral
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/28/2025Set Price Target$70.00$72.00
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
10/28/2025Downgrade$69.93$72.00Hold
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
9/25/2025Boost Price Target$73.04$85.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
9/19/2025Reiterated Rating$2.38$12.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
9/17/2025Reiterated Rating$5.67$14.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
9/16/2025Reiterated Rating$54.49$60.00Buy
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
9/10/2025Reiterated Rating$47.34$75.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
8/13/2025Reiterated Rating$6.02$14.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
8/13/2025Reiterated Rating$18.93$25.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
8/13/2025Reiterated Rating$33.51$60.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
8/13/2025Reiterated Rating$2.66$20.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
8/11/2025Reiterated Rating$16.42$60.00Buy
Arbutus Biopharma Corporation stock logo
ABUS
Arbutus Biopharma
8/11/2025Reiterated Rating$3.40$5.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
8/8/2025Lower Price Target$2.23$12.00Buy
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
8/8/2025Reiterated Rating$5.38$35.00Buy
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
8/8/2025Reiterated Rating$2.05$4.00Buy
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
8/8/2025Reiterated Rating$47.52$75.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
8/7/2025Reiterated Rating$2.64$20.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
8/1/2025Boost Price Target$392.24$400.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
7/29/2025Lower Price Target$9.31$38.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
7/1/2025Reiterated Rating$5.72$14.00Buy
iBio, Inc. stock logo
IBIO
iBio
6/25/2025Reiterated Rating$0.75$5.00Buy
Monopar Therapeutics Inc. stock logo
MNPR
Monopar Therapeutics
6/23/2025Initiated Coverage$32.86$60.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
6/17/2025Reiterated Rating$11.48$50.00Buy
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
6/13/2025Reiterated Rating$5.59$35.00Buy
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
6/9/2025Boost Price Target$33.13$75.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
5/15/2025Reiterated Rating$2.01$20.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
5/13/2025Reiterated Rating$13.97$60.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
5/13/2025Reiterated Rating$2.94$20.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
5/13/2025Reiterated Rating$5.76$14.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
5/9/2025Reiterated Rating$11.32$50.00Buy
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
5/9/2025Lower Price Target$3.56$35.00Buy
Seres Therapeutics, Inc. stock logo
MCRB
Seres Therapeutics
5/8/2025Reiterated Rating$8.29$6.00Neutral
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
5/7/2025Reiterated Rating$26.26$65.00Buy
iBio, Inc. stock logo
IBIO
iBio
5/5/2025Reiterated Rating$1.01$5.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
5/2/2025Boost Price Target$255.13$325.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
4/28/2025Reiterated Rating$6.18$14.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
4/22/2025Reiterated Rating$2.90$20.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
4/16/2025Initiated Coverage$13.40$25.00Buy
Sonnet BioTherapeutics Holdings, Inc. stock logo
SONN
Sonnet BioTherapeutics
4/7/2025Reiterated Rating$1.25$20.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
4/1/2025Lower Price Target$1.40$20.00Buy
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
4/1/2025Reiterated Rating$3.24$20.00Buy
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
3/28/2025Reiterated Rating$2.07$6.00Buy
Arbutus Biopharma Corporation stock logo
ABUS
Arbutus Biopharma
3/28/2025Reiterated Rating$3.27$5.00Buy
Sonnet BioTherapeutics Holdings, Inc. stock logo
SONN
Sonnet BioTherapeutics
3/28/2025Reiterated Rating$1.31$20.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
3/21/2025Reiterated Rating$253.60$300.00Buy
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
3/20/2025Reiterated Rating$6.45$14.00Buy
Seres Therapeutics, Inc. stock logo
MCRB
Seres Therapeutics
3/20/2025Reiterated Rating$14.64$25.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/17/2025Reiterated Rating$12.22$50.00Buy
ProQR Therapeutics N.V. stock logo
PRQR
ProQR Therapeutics
3/14/2025Reiterated Rating$1.74$4.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
2/28/2025Reiterated Rating$13.30$50.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
2/26/2025Reiterated Rating$245.20$300.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
2/11/2025Reiterated Rating$19.92$60.00Buy
Coya Therapeutics, Inc. stock logo
COYA
Coya Therapeutics
2/6/2025Reiterated Rating$7.00$14.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
1/29/2025Reiterated Rating$2.28$25.00Buy
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
1/10/2025Reiterated Rating$15.46$50.00Buy